Upcoming FDA decision on small cap company's Pain drug on July 10th

Upcoming FDA decision on a small cap company's drug for Pain expected on July 10th. The decision was expected on June 12th but FDA pushed back the decision. If the FDA approves this drug, it will compete directly with (stock symbol). To read about our opinion on whether the drug will be approved or not, along with details of the company, the drug, the disease, the other player in this area, the market and the sales potential of the drug (if approved), get a FREE report at: http://www.newbiomedicine.com